Rule · NAMFISA · 24 Mar 2020
The Registrar of Medical Aid Funds declares the curtailment of benefits for COVID-19 diagnostic testing and treatment as an undesirable practice under section 4(9) of the Medical Aid Funds Act, 1995. This prohibition applies to medical aid funds that require members to pay upfront for tests or refund payments only upon positive results. Funds are required to ensure members meeting WHO criteria have access to testing and recommended healthcare within their benefit limits. Any contravention of this notice will be addressed according to the Act's provisions.
NAMFISA
NAMIBIA FINANCIAL
INSTITUTIONS SUPERVISORY AUTHORITY
COVID-19 PANDEMIC
NOTICE IN TERMS OF SECTION 4(9) OF THE MEDICAL AID FUNDS ACT, 1995 (ACT NO.23 OF 1995)
The Registrar hereby:
a) indicates his intention to declare the following practise as undesirable in terms of section 4(9) of the Medical Aid Funds Act, 1995 (Act No.23 of 1995). The below will be gazetted as soon as possible and the industry is hereby given notice of the Registrar's intention, in order, for it to prepare and implement accordingly.
Following reports of confirmed cases of the coronavirus disease, commonly known as COVID-19, in Namibia and the declaration by the President of the Republic of Namibia His Excellency Hage G. Geingob of a state of emergency, certain medical aid funds ("Funds") have taken measures to minimize the impact of COVID-19 on the business of the Funds.
The World Health Organization ("WHO") has declared that "Diagnostic testing for COVID-19 is critical to tracking the virus, understanding epidemiology, informing case management, and to suppressing transmission." (WHO, 2020) Having regard to the seriousness of the COVID-19 pandemic and its implication on human life, it is imperative that members of Funds who meet the criteria for laboratory testing, be afforded access to the diagnostic testing, and subsequent healthcare treatment recommended by WHO, in accordance with their benefit option limits.
Against this background and under section 4(9) of the Act I hereby declare the practice of the curtailment of the use of benefits that members are entitled to in terms of the rules of Funds as an undesirable practice (e.g. requiring members to pay upfront for a COVID-19 test, or refunding members for upfront payments only if the result of the COVID-19 test is positive), is declared an undesirable
Page 1 of 2
Tel: +264 61 290 5000, Fax: +264 61 290 5157, PO Box 21250, Windhoek, Namibia, 154 Independence Ave, Sanlam Centre, www.namfisa.com.na
practice. This practice is not in the interest of the public, which is the basis on which Funds were established as envisioned in section 24(2)(a) of the Act.
In terms of section 28 of the Act, the Registrar is cognizant that every Fund seeks to carry on its business in accordance with sound business principles to preserve its financial soundness. In this regard, Funds are urged to find a balance between maintaining financial soundness and not creating additional financial burdens to members of the Funds, especially in light of the worldwide pandemic
Any contravention of this notice will be dealt with in accordance with the provisions of the Act.
Kenneth S. Matomola
REGISTRAR OF MEDICAL AID FUNDS
Windhoek, 24 March 2020
Page 2 of 2
Note from RegAlert. AI assistants can read this document in full, and search 70,000+ more, through the RegAlert MCP connector (https://mcp.regalert.today/mcp). Free with an account. How to connect ChatGPT, Claude or Cursor.
More like this from NAMFISA
We email you every new NAMFISA publication the day it's published.
Source: Namibia Financial Institutions Supervisory Authority — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works
In RegAlert: added · updated